Photobiomodulation Therapy (red/NIR LEDs) Reduced the Length of Stay in Intensive Care Unit and Improved Muscle Function: A Randomized, Triple-blind, and Sham-controlled Trial

Context: Photobiomodulation therapy (PBMT) has been widely used to improve strength, fatigue resistance and increase muscle mass in healthy individuals. These effects could help critically ill patients admitted to intensive care units (ICUs) who show reduced mobility and muscle strength. ICU-acquired weakness lessens overall health and increases the patient's length of stay in the ICU.

Objective: This study evaluated the effects of PBMT using low intensity light-emitting diodes (LEDs) on the mobility and muscle strength (functional capacity) and length of stay of patients admitted to hospital ICU.

Methods: This randomized, triple-blind, sham-controlled trial was conducted in a hospital ICU. Sixty patients were randomly assigned to two equal groups: (a) PBMT and (b) Sham. PBMT was applied daily to patients until their discharge from the ICU, using a flexible neoprene array of 264 LEDs (120 at 635 nm, 1.2 mW each; 144 at 880 nm, 15 mW each) for 90s (207.36 Joules) at each site. Ten sites were located bilaterally on the thighs, legs, arms, and forearms ventrally and dorsally, 15 min totaling 2,073.6 Joules per session. Outcomes were length of stay (in h) until discharge from the ICU, muscle strength by the Medical Research Council (MRC) score and handgrip dynamometry (HGD), patient mobility by Intensive Care Unit Mobility Scale (IMS) and the Simplified Acute Physiology Score 3 (SAPS 3) for predicting mortality of patients admitted to the ICU.

Results: PBMT reduced the average length of stay in the ICU by ~30% (p = 0.028); increased mobility (IMS: 255% vs. 110% p = 0.007), increased muscle strength (MRC: 12% vs. -9% p = 0.001) and HGD (34% vs. -13% p < 0.001), and the SAPS3 score was similar (p > 0.05).

Conclusion: The results suggest that daily PBMT can reduce the length of stay of ICU patients and increase muscle strength and mobility.

Citing Articles

Acute Sarcopenia: Systematic Review and Meta-Analysis on Its Incidence and Muscle Parameter Shifts During Hospitalisation.

Aldrich L, Ispoglou T, Prokopidis K, Alqallaf J, Wilson O, Stavropoulos-Kalinoglou A J Cachexia Sarcopenia Muscle. 2024; 16(1):e13662.

PMID: 39690131 PMC: 11695106. DOI: 10.1002/jcsm.13662.

References

Lee J, Waak K, Grosse-Sundrup M, Xue F, Lee J, Chipman D . Global muscle strength but not grip strength predicts mortality and length of stay in a general population in a surgical intensive care unit. Phys Ther. 2012; 92(12):1546-55. DOI: 10.2522/ptj.20110403. View

De Marchi T, Francio F, Ferlito J, Weigert R, de Oliveira C, Merlo A . Effects of Photobiomodulation Therapy Combined with Static Magnetic Field in Severe COVID-19 Patients Requiring Intubation: A Pragmatic Randomized Placebo-Controlled Trial. J Inflamm Res. 2021; 14:3569-3585. PMC: 8318710. DOI: 10.2147/JIR.S318758. View

Heiskanen V, Hamblin M . Photobiomodulation: lasers vs. light emitting diodes?. Photochem Photobiol Sci. 2018; 17(8):1003-1017. PMC: 6091542. DOI: 10.1039/c8pp90049c. View

Ali N, OBrien Jr J, Hoffmann S, Phillips G, Garland A, Finley J . Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008; 178(3):261-8. DOI: 10.1164/rccm.200712-1829OC. View

Ferraresi C, Dos Santos R, Marques G, Zangrande M, Leonaldo R, Hamblin M . Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players. Lasers Med Sci. 2015; 30(4):1281-7. DOI: 10.1007/s10103-015-1728-3. View

Dellagrana R, Rossato M, Orssatto L, Sakugawa R, Baroni B, Diefenthaeler F . Effect of Photobiomodulation Therapy in the 1500 m Run: An Analysis of Performance and Individual Responsiveness. Photobiomodul Photomed Laser Surg. 2020; 38(12):734-742. DOI: 10.1089/photob.2019.4785. View

Macagnan F, Baroni B, Cristofoli E, Godoy M, Schardong J, Plentz R . Acute effect of photobiomodulation therapy on handgrip strength of chronic kidney disease patients during hemodialysis. Lasers Med Sci. 2018; 34(4):835-840. DOI: 10.1007/s10103-018-2593-7. View

Scontri C, Magalhaes F, Damiani A, Hamblin M, Zamuner A, Ferraresi C . Dose and time-response effect of photobiomodulation therapy on glycemic control in type 2 diabetic patients combined or not with hypoglycemic medicine: A randomized, crossover, double-blind, sham-controlled trial. J Biophotonics. 2023; 16(10):e202300083. PMC: 10662441. DOI: 10.1002/jbio.202300083. View

Farhan H, Moreno-Duarte I, Latronico N, Zafonte R, Eikermann M . Acquired Muscle Weakness in the Surgical Intensive Care Unit: Nosology, Epidemiology, Diagnosis, and Prevention. Anesthesiology. 2015; 124(1):207-34. DOI: 10.1097/ALN.0000000000000874. View

10.

Ferraresi C, Parizotto N, de Sousa M, Kaippert B, Huang Y, Koiso T . Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation [J. Biophotonics 8, No. 9, 740-754 (2015)]. J Biophotonics. 2016; 9(9):976. DOI: 10.1002/jbio.201680087. View

11.

Tipping C, Bailey M, Bellomo R, Berney S, Buhr H, Denehy L . The ICU Mobility Scale Has Construct and Predictive Validity and Is Responsive. A Multicenter Observational Study. Ann Am Thorac Soc. 2016; 13(6):887-93. DOI: 10.1513/AnnalsATS.201510-717OC. View

12.

de Souza G, Ferraresi C, Moreno M, Pessoa B, Damiani A, Filho V . Acute effects of photobiomodulation therapy applied to respiratory muscles of chronic obstructive pulmonary disease patients: a double-blind, randomized, placebo-controlled crossover trial. Lasers Med Sci. 2019; 35(5):1055-1063. DOI: 10.1007/s10103-019-02885-3. View

13.

Klawitter F, Ehler J, Bajorat R, Patejdl R . Mitochondrial Dysfunction in Intensive Care Unit-Acquired Weakness and Critical Illness Myopathy: A Narrative Review. Int J Mol Sci. 2023; 24(6). PMC: 10052131. DOI: 10.3390/ijms24065516. View

14.

Chow R, Johnson M, Lopes-Martins R, Bjordal J . Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet. 2009; 374(9705):1897-908. DOI: 10.1016/S0140-6736(09)61522-1. View

15.

Hamblin M . Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol. 2017; 94(2):199-212. PMC: 5844808. DOI: 10.1111/php.12864. View

16.

de Oliveira Francisco C, Beltrame T, Hughson R, Milan-Mattos J, Ferroli-Fabricio A, Galvao Benze B . Effects of light-emitting diode therapy (LEDT) on cardiopulmonary and hemodynamic adjustments during aerobic exercise and glucose levels in patients with diabetes mellitus: A randomized, crossover, double-blind and placebo-controlled clinical trial. Complement Ther Med. 2019; 42:178-183. DOI: 10.1016/j.ctim.2018.11.015. View

17.

Nordon-Craft A, Moss M, Quan D, Schenkman M . Intensive care unit-acquired weakness: implications for physical therapist management. Phys Ther. 2012; 92(12):1494-506. PMC: 3513482. DOI: 10.2522/ptj.20110117. View

18.

Huang Y, Chen A, Carroll J, Hamblin M . Biphasic dose response in low level light therapy. Dose Response. 2009; 7(4):358-83. PMC: 2790317. DOI: 10.2203/dose-response.09-027.Hamblin. View

19.

Beltrame T, Ferraresi C, Parizotto N, Bagnato V, Hughson R . Light-emitting diode therapy (photobiomodulation) effects on oxygen uptake and cardiac output dynamics during moderate exercise transitions: a randomized, crossover, double-blind, and placebo-controlled study. Lasers Med Sci. 2018; 33(5):1065-1071. DOI: 10.1007/s10103-018-2473-1. View

20.

Baroni B, Rodrigues R, Freire B, Franke R, Geremia J, Vaz M . Effect of low-level laser therapy on muscle adaptation to knee extensor eccentric training. Eur J Appl Physiol. 2014; 115(3):639-47. DOI: 10.1007/s00421-014-3055-y. View